Loading data for LABD — first visit, this takes a few seconds.
Direxion Daily S&P Biotec... (LABD)
NYSEArca: LABD
· Echtzeitkurs · USD
5.93
-1.27 (-17.64%)
Zum Schluss: Aug 19, 2026, 8:00 PM
5.95
+0.34%
Nachbörslich: 7:59 PM
Direxion Daily S&P Biotech Bear 3X Shares (LABD) Stock Price, Analysis & Data
-17.64% (1D)
Keine Daten verfügbar
| Geld | 5.95 |
| Marktkapitalisierung | n/a |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | n/a |
| KUV (TTM) | n/a |
| Earnings Date | n/a |
| Brief | 5.93 |
| Volumen | 26,917,724 |
| Ø Vol. (20D) | 10,814,069 |
| Eröffnung | 6.48 |
| Vortagesschluss | 7.20 |
| Tagesspanne | 5.92 - 6.59 |
| 52-Wk Range | 5.92 - 60.90 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über LABD
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. T...
Vollständiges UnternehmensprofilFinanzielle Entwicklung
Im Jahr undefined betrug der Umsatz von Direxion Daily S&P Biotech Bear 3X Shares n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.
Finanzberichte